title: [Control of treatment efficacy in patients with diabetic foot syndrome and peripheral angiopathy].
abstract: The preparation of deproteinized hemoderivate, obtained from the calf blood, was used in complex of treatment of the patients, suffering the ischemic forms of the diabetic foot syndrome (DFS). The impact of treatment on a partial pressure of the oxygen (TcPO2) on the foot back was studied up. In noncritical ischemia of the lower extremities tissues there were established a trustworthy increase of TcPO2 in patients as well as a positive dynamics of the wounds healing. In a critical ischemia the results are heterogenous due to presence of coexistant factors, although a stable positive effect was noted.
authors: M B
authors: MB
authors: Horobeĭko
mesh_terms: D000818:Animals; D001785:Blood Gas Monitoring, Transcutaneous; D001802:Blood Substitutes / Q000737:chemistry / Q000302:isolation & purification / Q000627:therapeutic use*; D002417:Cattle; D017719:Diabetic Foot / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery; D005528:Foot / Q000098:blood supply / Q000473:pathology / Q000601:surgery; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D010100:Oxygen / Q000378:metabolism; D016491:Peripheral Vascular Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism / Q000601:surgery; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects
chemical_list: D001802:Blood Substitutes; D010100:Oxygen